Human & Work is Europe's leading consultancy group dedicated to people issues in the workplace, helping HR managers to take care of their teams and their organizations.
Since GENEO's investment alongside Bpifrance and NCI in 2019, David Mahé and his teams, with the support of GENEO Capital Entrepreneur, have deployed a strategic plan aimed at making Human & Work the European leader in people at work.
Since GENEO's investment alongside Bpifrance and NCI in 2019, David Mahé and his teams, with the support of GENEO Capital Entrepreneur, have deployed a strategic plan aimed at making Human & Work the European leader in people at work.
With offices in France, Italy, Spain and Germany, the group's 270 employees support over 1,000 companies and their 8 million employees worldwide.
The acquisition of Human & Work by a world-class Canadian healthcare group is intended to extend the Group's capabilities in Europe, to meet the growing demand for corporate services in this region, and to broaden their range of leading employee health and wellness services to include new expertise in consulting, training and leadership development.
The acquisition of Human & Work by a world-class Canadian healthcare group is intended to extend the Group's capabilities in Europe, to meet the growing demand for corporate services in this region, and to broaden their range of leading employee health and wellness services to include new expertise in consulting, training and leadership development.